Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Kelly

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Medical Journal of Australia|November 19, 2013
Immigration screening for latent tuberculosis infectionDavid W J Griffin, Mark D Kelly
The Medical Journal of Australia|September 22, 2012
The use of key performance indicators to benchmark individual clinic performance in managing a complex chronic infectious diseaseMark D Kelly, Jennifer K Broom, Sharon Young
Plos One|November 9, 2013
Co-morbidity, ageing and predicted mortality in antiretroviral treated Australian men: a quantitative analysisLuis Furuya-Kanamori, Mark D Kelly, Samantha J McKenzie
AIDS (London, England)|August 4, 2010
Acute hepatitis B virus infection despite previous immunization in the context of recent HIV-1 infectionCarol R Emerson, Jeffrey J Post, Mark D Kelly
Sexual Health|June 2, 2015
Risk of cardiovascular disease in HIV-positive Queensland men receiving combined antiretroviral therapyLuis Furuya-Kanamori, Mark D Kelly, Samantha J McKenzie
The Medical Journal of Australia|January 21, 2014
Implementation of an HIV assessment tool leads to significant improvements in outpatient careJennifer K Broom, Mark D Kelly, Alex F Broom
AIDS (London, England)|August 10, 2012
Tenofovir-associated proteinuriaMark D Kelly, Abby Gibson, Harry Bartlett, et al.
ANZ Journal of Surgery|March 7, 2018
Addressing social influences reduces antibiotic duration in complicated abdominal infection: a mixed methods studyJennifer Broom, Chin Li Tee, Alex Broom, et al.
Journal of Clinical Immunology|September 21, 2011
Alterations in immune function are associated with liver enzyme elevation in HIV and HCV co-infection after commencement of combination antiretroviral therapyBarbara Anne Cameron, Carol R Emerson, Cassy Workman, et al.
Antiviral Therapy|April 8, 2014
Recent trends in early stage response to combination antiretroviral therapy in AustraliaHamish McManus, Jennifer F Hoy, Ian Woolley, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Medical Journal of Australia|November 19, 2013
Immigration screening for latent tuberculosis infectionDavid W J Griffin, Mark D Kelly
The Medical Journal of Australia|September 22, 2012
The use of key performance indicators to benchmark individual clinic performance in managing a complex chronic infectious diseaseMark D Kelly, Jennifer K Broom, Sharon Young
Plos One|November 9, 2013
Co-morbidity, ageing and predicted mortality in antiretroviral treated Australian men: a quantitative analysisLuis Furuya-Kanamori, Mark D Kelly, Samantha J McKenzie
AIDS (London, England)|August 4, 2010
Acute hepatitis B virus infection despite previous immunization in the context of recent HIV-1 infectionCarol R Emerson, Jeffrey J Post, Mark D Kelly
Sexual Health|June 2, 2015
Risk of cardiovascular disease in HIV-positive Queensland men receiving combined antiretroviral therapyLuis Furuya-Kanamori, Mark D Kelly, Samantha J McKenzie
The Medical Journal of Australia|January 21, 2014
Implementation of an HIV assessment tool leads to significant improvements in outpatient careJennifer K Broom, Mark D Kelly, Alex F Broom
AIDS (London, England)|August 10, 2012
Tenofovir-associated proteinuriaMark D Kelly, Abby Gibson, Harry Bartlett, et al.
ANZ Journal of Surgery|March 7, 2018
Addressing social influences reduces antibiotic duration in complicated abdominal infection: a mixed methods studyJennifer Broom, Chin Li Tee, Alex Broom, et al.
Journal of Clinical Immunology|September 21, 2011
Alterations in immune function are associated with liver enzyme elevation in HIV and HCV co-infection after commencement of combination antiretroviral therapyBarbara Anne Cameron, Carol R Emerson, Cassy Workman, et al.
Antiviral Therapy|April 8, 2014
Recent trends in early stage response to combination antiretroviral therapy in AustraliaHamish McManus, Jennifer F Hoy, Ian Woolley, et al.
Pageof 2